Quintiles IMS

Articles

A recent pharmaphorum webinar brought four experts together to discuss the future of market access for specialist medicines in the UK.

News

Pulmonary fibrosis drug developer Avalyn prices its IPO at around $300m, as Seaport and Hemab both target $180m-plus from their listings.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.